Explicit|||62..69||because||0|because|||Contingency.Cause|||||||||||35..61|0|of its safety profile, but||||||||70..96|0|it is an entirely new drug|||||||||||||
Explicit|||58..61||but||0|but|||Comparison.Contrast|||||||||||35..56|0|of its safety profile||||||||62..96|0|because it is an entirely new drug|||||||||||||
Explicit|||27..34||because||0|because|||Contingency.Cause|||||||||||0..6|0|belviq||||||||7..26;35..111|0|stands out not just of its safety profile, but because it is an entirely new drug, tenthoff said|||||||||||||
Explicit|||113..124||by contrast||1|by contrast|||Comparison.Contrast|||||||||||0..111|0|belviq stands out not just because of its safety profile, but because it is an entirely new drug, tenthoff said||||||||125..211|1|the competitors from vivus and orexigen are combinations of two already approved drugs|||||||||||||
